NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
Haemnet/LinkedIn
Sep 17, 2025, 16:28

Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy

Haemnet posted on LinkedIn:

”Shared decision-making is a real buzzword in modern haemophilia care. But how do you ensure that it moves beyond lip service to truly empower patients in decisions about their treatment?

This question underlies a new paper in The Journal of Haemophilia Practice, exploring the experience of people with haemophilia A switching from factor VIII prophylaxis to emicizumab.

The authors conducted in-depth qualitative interviews with participants with severe haemophilia A without FVIII inhibitors from the Swedish cohort of the HemiNorth 2 study. Alongside the process of ‘adapting to a new   reality’ and a sense of normality, they found that ‘shattered expectations’ emerged as a key theme, highlighting gaps in knowledge among the patient group and the need to ensure that appropriate, patient-friendly information   dis available to support treatment decisions.

Find out more, open access, in The Journal of Haemophilia

Practice here.”

Title: Perceived experiences of people with severe haemophilia A switching from factor VIII prophylaxis to emicizumab

Authors: Linda Myrin-Westesson, Anna Olsson

Haemnet

Stay updated with Hemostasis Today.

A Anna Olsson Emicizumab Factor VIII Prophylaxis Haemnet haemophilia Health Hematology Hemostasis Hemostasis Today Linda Myrin-Westesson Medicine The Journal of Haemophilia Practice thrombosis
NewsFeed